Related Experiment Video
Updated: Dec 25, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Violaceous nodules in an HIV-positive man
Brian L Scott, Arturo R Dominguez, Khang D Nguyen1
1University of Texas Southwestern Medical Center, Dallas, TX. Khang.Nguyen@utsouthwestern.edu.
Plasmablastic lymphoma (PBL), an aggressive cancer linked to immune suppression and Epstein-Barr virus (EBV), can manifest on the skin. This case highlights PBL presenting as leg ulcers and nodules in an HIV-positive individual.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Plasmablastic lymphoma (PBL) is a rare, aggressive non-Hodgkin lymphoma.
- PBL is strongly associated with human immunodeficiency virus (HIV) infection and Epstein-Barr virus (EBV) reactivation.
- Immunosuppression is a key risk factor for PBL development.
Observation:
- A case of PBL presenting with unusual cutaneous manifestations is described.
- The patient was an HIV-positive male with leg ulcers and violaceous exophytic nodules.
- These skin lesions represented a rare presentation of PBL.
Findings:
- The study reviews the clinical features, histological findings, and diagnostic considerations for PBL.
- Cutaneous involvement in PBL, though uncommon, can mimic other dermatological conditions.
- Diagnostic challenges include differentiating PBL from other EBV-associated lymphoproliferative disorders.
Implications:
- This case underscores the importance of considering PBL in the differential diagnosis of skin lesions in immunocompromised patients.
- Early recognition and diagnosis of cutaneous PBL are crucial for timely treatment and improved outcomes.
- Further research into the pathogenesis and optimal management of PBL, particularly its extranodal and cutaneous manifestations, is warranted.
More Related Videos
Related Concept Videos
Retroviruses
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Endocarditis II: Clinical Features of Infective Endocarditis
Subviral Agents
Retrovirus Life Cycles

